제6회 삼성서울병원 암병원 심포지엄 안녕하세요. 제 6회 삼성서울병원 암병원 심포지엄을 개최합니다. 관심 있는 분들의 많은 참여 바랍니다. 일시 : 2022년 11월 19일(토) 09:00 ~ 17:00 장소 : 삼성서울병원 암병원 지하 1층 강당 링크 : http://www.medioffice.or.kr/conference/index.php?svc_name=program&ptype=view&cidx=230&cmidx=2240
| 시간 | 강의제목 | 발표자 | 소속 |
|---|
| 08:30~09:00 | Registration | | | | 09:00~09:05 | Opening
(Executive Vice President, SMC & General
Director, Cancer Center) | Woo Yong Lee, M.D. | SMC, Korea | | 09:05~09:10 | Welcome Address
(President & CEO Samsung Medical Center) | Seung Woo Park, M.D. | SMC, Korea | | Session I. CAR T-cell therapy in lymphoid malignancy | Ki Woong Sung, M.D. | SMC, Korea | | 09:10~09:40 | Current status of CAR T-cell therapy in SMC | Won Seog Kim, M.D. | SMC, Korea | | 09:40~10:10 | Approved and emerging CAR T-cell therapy
in lymphoma | Anna Sureda, M.D. | Institut Català d'Oncologia-Hospitalet, Barcelona, Spain | | 10:10~10:40 | CAR T-cell therapy in pediatric malignancy | Hee Young Ju, M.D | SMC, Korea | | 10:40~11:00 | Coffee Break | | | | Session II. CAR T-cell therapy in solid tumors | Joon Oh Park, M.D | SMC, Korea | | 11:00~11:30 | CAR T-cell therapy in gastric cancer | Changsong Qi, M.D. | Peking University, China | | 11:30~12:00 | CAR T-cell therapy for solid tumors based on a new concept | Hiroshi Fujiwara, M.D. | Mie University, Japan | | 12:00~13:00 | Lunch | | | | Session Ⅲ. CAR T-cell therapy for future clinical practice | Yeup Yoon, Ph.D. | SMC, Korea | | 13:00~13:30 | Practical issues of CAR T-cell therapy | Seok Jin Kim, M.D. | SMC, Korea | | 13:30~14:00 | Reimagining the Future of Cancer Care with CAR-T | Bernd Eschgfaeller, Ph.D. | Novartis, Switzerland | | 14:00~14:30 | Gene editing and CAR T-cell therapy | Dae Sik Kim, Ph.D. | Sungkyunkwan University, Korea | | 14:30~14:50 | Coffee Break | | | | Session IV. Next generation CAR T-cell therapy | Won Seog Kim, M.D. | SMC, Korea | | 14:50~15:20 | Engineering Next-Generation CAR T-cell therapy for cancer therapy | Yvonne Chen, Ph.D. | University of California, Los Angeles, USA | | 15:20~15:50 | Next Generation CAR T-cell therapy against hematological malignancies | Kyungho Choi, M.D. | SNU, Korea | | 15:50~16:20 | iPSC-derived CAR T-cell therapy | Maria Themeli, M.D. | Cancer Center Amsterdam, Netherlands | | 16:20~16:50 | Towards Next-generation T-cell Engineering for Cancer | Chan Hyuk Kim, Ph.D. | KAIST, Korea | | 16:50~17:00 | Closing
(Director, Division of Hematology-Oncology
CAR T-cell Therapy Center) | Won Seog Kim, M.D. | SMC, Korea |
|
